Discontinuation of antipsychotic medication-time to rethink trial design.
Speyer H, Begemann M, Albert N, Weller A, Nordentoft M, Veling W, Sommer IE, Allott K, Killackey E.
Speyer H, et al. Among authors: veling w.
Lancet Psychiatry. 2020 Oct;7(10):841-842. doi: 10.1016/S2215-0366(20)30340-0.
Lancet Psychiatry. 2020.
PMID: 32949515
No abstract available.